Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

MicroRNA-21 as a biomarker for ovarian cancer detection

Indonesian Journal of Biotechnology · Vol. 23 No. 1 (2018) · hlm. 35–39

DOI
10.22146/ijbiotech.35692
ISSN
2089-2241, 0853-8654
Terbit
2018-06-11
Penerbit
Universitas Gadjah Mada
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Ovarian cancer is a lethal disease. One of the problems faced by patients with ovarian cancer is the lack of symptoms in its early stages, which results in it only being detected when it is at an advanced stage. Therefore, there is an urgent need for biomarkers that can predict ovarian cancer precisely. The purpose of this study was to determine the expression of microRNA-21 as a predictive biomarker candidate in both early- and advanced-stage ovarian cancer. This was a cross-sectional study using the blood plasma of 21 healthy control subjects and 37 blood plasma samples from patients with ovarian cancer. Blood plasmas were collected, from which the RNA was isolated. Based on the RNA, the cDNA was synthesized and run through qPCR, the results of which were analyzed using the Livak method. The results showed an upregulation of microRNA-21 in the advanced stage by 2.14 fold compared with the early stage, and 6.13 fold compared with the healthy controls (p < 0.05). The upregulation of microRNA-21 in early-stage ovarian cancer was 2.86 fold compared with the healthy control subjects (p < 0.05). In addition, there was an increase in the expression of microRNA-21 in ovarian cancer by 4.14 fold compared with the healthy controls (p < 0.05). Based on these results, it can be concluded that the expression of microRNA 21 upregulated with the severity of the disease.

Kata kunci

Jaringan kolaborasi para penulis

34 penulis · 113 tautan kepenulisan bersama · 53 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • Universitas Muhammadiyah Semarang
  • State University of Semarang
  • Diponegoro University
  • Universitas Pattimura
  • Lombok Institute of Technology
  • Sekolah Tinggi Ilmu Kesehatan Kepanjen
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Dewi AgustinaUniversitas Gadjah Mada2
Pamungkas Bagus SatriyoUniversitas Gadjah Mada2
Retno Sri IswariState University of Semarang1
Muhammad Husein GasemAfiliasi tidak diketahui1
Muchamad DafipState University of Semarang1
Winarto RekiDiponegoro University1
Meutia Srikandi FitriaUniversitas Muhammadiyah Semarang1
Wasito WasitoUniversitas Gadjah Mada1
Al SupartinahUniversitas Gadjah Mada1
Pinandi Sri PudyaniUniversitas Gadjah Mada1
Sri SuparwitriUniversitas Gadjah Mada1
Sri DarmawatiUniversitas Muhammadiyah Semarang1
Hapsari Sulistya KusumaUniversitas Muhammadiyah Semarang1
Dwi Aris Agung NugrahaningsihUniversitas Gadjah Mada1
Fita NilasariUniversitas Gadjah Mada1
Jecklyn Shindy TemartenanUniversitas Pattimura1
Hairil FiqriLombok Institute of Technology1
Dedi KurniawanSekolah Tinggi Ilmu Kesehatan Kepanjen1
Erni SamutriUniversitas Alma Ata1
Wiwit Ananda Wahyu SetyaningsihUniversitas Gadjah Mada1
Eriyono Budi WijoyoUniversitas Muhammadiyah Tangerang1
Apri Nur WulandariAfiliasi tidak diketahui1
Gatot SuparmantoUniversitas Kusuma Husada Surakarta1
Bayu Fandhi AchmadUniversitas Gadjah Mada1
Listyana Natalia RetnaningsihUniversitas Respati Yogyakarta1
Putri Eka SudiartiUniversitas Pahlawan Tuanku Tambusai1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://jurnal.ugm.ac.id/ijbiotech/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">MicroRNA-21 as a biomarker for ovarian cancer detection</dc:title>
	<dc:creator>Kartika, Aprilia Indra</dc:creator>
	<dc:creator>Chasanah, Siti Nur</dc:creator>
	<dc:creator>Fitriawan, Akbar Satria</dc:creator>
	<dc:creator>Tanjung, Dewi Sahfitri</dc:creator>
	<dc:creator>Trirahmanto, Addin</dc:creator>
	<dc:creator>Pradjatmo, Heru</dc:creator>
	<dc:creator>Aryandono, Teguh</dc:creator>
	<dc:creator>Haryana, Sofia Mubarika</dc:creator>
	<dc:subject xml:lang="en-US">microRNA-21; minimally invasive; ovarian cancer; predictive biomarker</dc:subject>
	<dc:description xml:lang="en-US">Ovarian cancer is a lethal disease. One of the problems faced by patients with ovarian cancer is the lack of symptoms in its early stages, which results in it only being detected when it is at an advanced stage. Therefore, there is an urgent need for biomarkers that can predict ovarian cancer precisely. The purpose of this study was to determine the expression of microRNA-21 as a predictive biomarker candidate in both early- and advanced-stage ovarian cancer. This was a cross-sectional study using the blood plasma of 21 healthy control subjects and 37 blood plasma samples from patients with ovarian cancer. Blood plasmas were collected, from which the RNA was isolated. Based on the RNA, the cDNA was synthesized and run through qPCR, the results of which were analyzed using the Livak method. The results showed an upregulation of microRNA-21 in the advanced stage by 2.14 fold compared with the early stage, and 6.13 fold compared with the healthy controls (p &lt; 0.05). The upregulation of microRNA-21 in early-stage ovarian cancer was 2.86 fold compared with the healthy control subjects (p &lt; 0.05). In addition, there was an increase in the expression of microRNA-21 in ovarian cancer by 4.14 fold compared with the healthy controls (p &lt; 0.05). Based on these results, it can be concluded that the expression of microRNA 21 upregulated with the severity of the disease.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Gadjah Mada</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2018-06-11</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Original Research Articles</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.ugm.ac.id/ijbiotech/article/view/35692</dc:identifier>
	<dc:identifier>10.22146/ijbiotech.35692</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Biotechnology; Vol 23, No 1 (2018); 35-39</dc:source>
	<dc:source>2089-2241</dc:source>
	<dc:source>0853-8654</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/view/35692/21225</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 The Author(s)</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>